PROK
Price
$1.61
Change
-$0.15 (-8.52%)
Updated
Jul 13 closing price
Capitalization
329.35M
23 days until earnings call
Intraday BUY SELL Signals
SANA
Price
$3.64
Change
-$0.21 (-5.45%)
Updated
Jul 13 closing price
Capitalization
1.02B
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PROK vs SANA

PROK vs SANA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PROK vs. SANA commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PROK is a Buy and SANA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (PROK: $1.61 vs. SANA: $3.64)
Brand notoriety: PROK and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PROK: 107% vs. SANA: 42%
Market capitalization -- PROK: $329.35M vs. SANA: $1.02B
PROK [@Biotechnology] is valued at $329.35M. SANA’s [@Biotechnology] market capitalization is $1.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PROK’s FA Score shows that 0 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • PROK’s FA Score: 0 green, 5 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, SANA is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PROK’s TA Score shows that 4 TA indicator(s) are bullish while SANA’s TA Score has 6 bullish TA indicator(s).

  • PROK’s TA Score: 4 bullish, 5 bearish.
  • SANA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SANA is a better buy in the short-term than PROK.

Price Growth

PROK (@Biotechnology) experienced а -19.10% price change this week, while SANA (@Biotechnology) price change was -8.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

PROK is expected to report earnings on Aug 06, 2026.

SANA is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SANA($1.02B) has a higher market cap than PROK($329M). SANA YTD gains are higher at: -10.565 vs. PROK (-28.125). PROK has higher annual earnings (EBITDA): -149.81M vs. SANA (-192.2M). PROK has more cash in the bank: 225M vs. SANA (101M). PROK has less debt than SANA: PROK (3.78M) vs SANA (75.3M). PROK has higher revenues than SANA: PROK (889K) vs SANA (0).
PROKSANAPROK / SANA
Capitalization329M1.02B32%
EBITDA-149.81M-192.2M78%
Gain YTD-28.125-10.565266%
P/E RatioN/AN/A-
Revenue889K0-
Total Cash225M101M223%
Total Debt3.78M75.3M5%
TECHNICAL ANALYSIS
Technical Analysis
PROKSANA
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 27 days ago
73%
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
PROK
Daily Signal:
Gain/Loss:
SANA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AUXIX37.400.02
+0.05%
Auxier Focus Institutional
GATMX18.93N/A
N/A
Goldman Sachs International T/M Eq A
JAMEX40.89N/A
N/A
Jamestown Equity
FSTKX40.39N/A
N/A
Federated Hermes MDT Large Cap Value Svc
FVWSX28.34N/A
N/A
Fidelity Series Opportunistic Insights

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RXRX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-8.52%
RXRX - PROK
50%
Loosely correlated
-7.30%
SANA - PROK
45%
Loosely correlated
-5.45%
BEAM - PROK
43%
Loosely correlated
-5.14%
CLDI - PROK
42%
Loosely correlated
-5.82%
RLYB - PROK
41%
Loosely correlated
+1.02%
More